Completed OBSERVATIONAL NCT00199537

Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer

Sponsor: Lawson Health Research Institute Internal Review Fund

Updated 8 times since 2017 Last updated: Jul 25, 2008 Started: Feb 28, 2005 Primary completion: Feb 29, 2008 Completion: Feb 29, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Bone Loss and Prostate Cancer, this trial is completed. The trial is conducted by Lawson Health Research Institute Internal Review Fund and has accumulated 8 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Apr 2025 — Present [monthly]

Completed
Jan 2025 — Apr 2025 [monthly]

Completed
Sep 2024 — Jan 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lawson Health Research Institute Internal Review Fund
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
University of Western Ontario, Canada

Data source: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, Canada